Cited by 1,690Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerChromatin Remodeling and Cancer

The DOI matches its Crossref record; 115 of the 122 references it cites were found in a registry or an index.

The RB and p53 pathways in cancer

Open access

Sherr, Charles J, McCormick, Frank·2002·Cancer Cell

Open this paper in CoChat — free account Open PDF

Abstract

The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(02)00102-2

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Self-citation
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citation
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“By inducing Arf and Ink4a in primary rodent fibroblasts, oncogenic Ras expression leads to growth arrest and premature senescence (Serrano et al., 1997; Ferbeyre et al., 2002).”
Background
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Untitled work
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585

Show all 122 references

Sorted by citations

Items 301–400 of 1,000

RB constrains lineage fidelity and multiple stages of tumour progression and metastasis
Walter, D. M., Yates, T. J., Ruiz-Torres, M., Kim-Kiselak, C., Gudiel, A. A., Deshpande, C. G., Wang, W., Cicchini, M., Stokes, K. L., Tobias, J. W., et al. (2019) · Nature · doi:10.1038/s41586-019-1172-9 · Cited by 84
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
Minoli, M., Kiener, M., Thalmann, G. N., Julio, M. K., & Seiler, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165670 · Cited by 86
Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands
Klopfleisch, R., & Gruber, A. D. (2009) · Research in Veterinary Science · doi:10.1016/j.rvsc.2008.12.010 · Cited by 84
Control of Tumorigenesis and Chemoresistance by the DEK Oncogene
Riveiro‐Falkenbach, E., & Soengas, M. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2330 · Cited by 84
E- and A-type cyclins as markers for cancer diagnosis and prognosis
Yasmeen, A., Berdel, W. E., Serve, H. L., & Müller‐Tidow, C. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.5.617 · Cited by 83
Modulation of Cell Cycle Components by Epigenetic and Genetic Events
Macaluso, M., Montanari, M., Cinti, C., & Giordano, A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.009 · Cited by 83
Structure-function analysis of the retinoblastoma tumor suppressor protein – is the whole a sum of its parts?
Dick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79
Distinct E2F‐mediated transcriptional program regulates p14 ARF gene expression
Komori, H., Enomoto, M., Nakamura, M., Iwanaga, R., & Ohtani, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600836 · Cited by 86
Impaired tRNA Nuclear Export Links DNA Damage and Cell-Cycle Checkpoint
Ghavidel, A., Kislinger, T., Pogoutse, O., Sopko, R., Jurišica, I., & Emili, A. (2007) · Cell · doi:10.1016/j.cell.2007.09.042 · Cited by 82
Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies
Mulvany, N. J., Allen, D. G., & Wilson, S. M. (2008) · Pathology · doi:10.1080/00313020802035907 · Cited by 83
Targeting Tumor Suppressor Networks for Cancer Therapeutics
Guo, X. E., Ngo, B., Modrek, A. S., & Lee, W. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106095151 · Cited by 89
The Role of Chaperone-Mediated Autophagy in Cell Cycle Control and Its Implications in Cancer
Andrade-Tomaz, M., de Souza, I., Rocha, C. R. R., & Gomes, L. R. (2020) · Cells · doi:10.3390/cells9092140 · Cited by 84
Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation
Bockstaele, L., Bisteau, X., Paternot, S., & Roger, P. P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01823-08 · Cited by 80
Cold-Inducible RNA-Binding Protein Bypasses Replicative Senescence in Primary Cells through Extracellular Signal-Regulated Kinase 1 and 2 Activation
Artero‐Castro, A., Callejas, F. D. B., Castellví, J., Kondoh, H., Carnero, A., Fernández-Marcos, P. J., Serrano, M., y Cajal, S. R., & LLeonart, M. E. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01386-08 · Cited by 82
Small cell lung cancer: Subtypes and therapeutic implications
Wang, W., Shulman, A., Amann, J. M., Carbone, D. P., & Tsichlis, P. N. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.001 · Cited by 83
Role of p16INK4A in Replicative Senescence and DNA Damage-Induced Premature Senescence in p53-Deficient Human Cells
Mirzayans, R., Andrais, B., Hansen, G., & Murray, D. L. (2012) · Biochemistry Research International · doi:10.1155/2012/951574 · Cited by 88
Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors
Wang, I., Meliton, L. N., Tretiakova, M., Costa, R. H., Kalinichenko, V. V., & Kalin, T. V. (2008) · Oncogene · doi:10.1038/onc.2008.60 · Cited by 81
The E2F family and the role of E2F1 in apoptosis
Wu, Z., Zheng, S., & Yu, Q. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.06.004 · Cited by 86
Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas☆
Liu, Y., Pang, J. C., Dong, S., Mao, B., Poon, W. S., & Ng, H. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.02.006 · Cited by 80
Dysregulated glycolysis as an oncogenic event
Mikawa, T., LLeonart, M. E., Takaori‐Kondo, A., Inagaki, N., Yokode, M., & Kondoh, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1840-3 · Cited by 85
EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling
Chen, J.-F., Luo, X., Xiang, L.-S., Li, H.-T., Zha, L., Li, N., He, J.-M., Xie, G.-F., Xie, X., & Liang, H.-J. (2106) · Oncotarget · doi:10.18632/oncotarget.9236 · Cited by 74
Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy
Zhu, Y., Dean, A. E., Horikoshi, N., Heer, C. D., Spitz, D. R., & Gius, D. R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120844 · Cited by 82
Restriction point regulation at the crossroads between quiescence and cell proliferation
Pennycook, B. R., & Barr, A. R. (2020) · FEBS Letters · doi:10.1002/1873-3468.13867 · Cited by 85
The Rb–E2F Transcriptional Regulatory Pathway in Tumor Angiogenesis and Metastasis
Schaal, C. M., Pillai, S., & Chellappan, S. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00004-4 · Cited by 80
Suppression of the novel ER protein Maxer by mutant ataxin‐1 in Bergman glia contributes to non‐cell‐autonomous toxicity
Shiwaku, H., Yoshimura, N., Tamura, T., Sone, M., Ogishima, S., Watase, K., Tagawa, K., & Okazawa, H. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.116 · Cited by 82
Retinoblastoma protein: a central processing unit
Poznić, M. (2009) · Journal of Biosciences · doi:10.1007/s12038-009-0034-2 · Cited by 79
Deregulated expression of LRBA facilitates cancer cell growth
Wang, J., Gamsby, J. J., Highfill, S. L., Mora, L. B., Bloom, G. C., Yeatman, T. J., Pan, T.-C., Ramne, A., Chodosh, L. A., Cress, W. D., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207567 · Cited by 79
Cancer of the esophagus and gastric cardia: recent advances*
Tytgat, G. N. J., Bartelink, H. G. M. M., Bernards, R., Giaccone, G., van Lanschot, J. J. B., Offerhaus, G. J. A., & Peters, G. J. (2004) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2004.00371.x · Cited by 77
The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes
Yu, H., McDaid, R., Lee, J., Possik, P. A., Li, L., Kumar, S. M., Elder, D. E., Belle, P. A. V., Gimotty, P. A., Guerra, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081057 · Cited by 85
Graphene-based immunosensor for electrochemical quantification of phosphorylated p53 (S15)
Xie, Y., Chen, A., Du, D., & Lin, Y. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.05.010 · Cited by 80
Regeneration, Stem Cells, and the Evolution of Tumor SuppressionPreprint
Pearson, B. J., & Alvarado, A. S. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.045 · Cited by 79
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function
Markey, M. P., Bergseid, J., Bosco, E. E., Stengel, K. R., Xu, H., Mayhew, C. N., Schwemberger, S. J., Braden, W. A., Jiang, Y., Babcock, G. F., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210450 · Cited by 78
MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer
Taneja, P., Frazier, D. P., Kendig, R. D., Maglic, D., Sugiyama, T., Kai, F., Taneja, N. K., & Inoue, K. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.31 · Cited by 85
FoxM1 Regulates Mammary Luminal Cell Fate
Carr, J. R., Kiefer, M. M., Park, H. J., Li, J., Wang, Z., Fontanarosa, J., DeWaal, D., Kopanja, D., Benevolenskaya, E. V., Guzman, G., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.05.005 · Cited by 81
Viral Epigenetics
Milavetz, B. I., & Balakrishnan, L. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1804-1_30 · Cited by 78
Smad3 phosphorylation by cyclin-dependent kinases
LIU, F. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.010 · Cited by 71
Introduction to the molecular basis of cancer metabolism and the Warburg effect
Ngo, D. C., Ververis, K., Tortorella, S. M., & Karagiannis, T. C. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3857-y · Cited by 80
RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation
Schade, A. E., Fischer, M., & DeCaprio, J. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz961 · Cited by 74
Genome homeostasis defects drive enlarged cells into senescence
Manohar, S., Estrada, M. E., Uliana, F., Vuina, K., Alvarez, P. M., de Bruin, R. A. M., & Neurohr, G. E. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.018 · Cited by 85
Virology and molecular pathogenesis of HPV (human papillomavirus)associated oropharyngeal squamous cell carcinoma
Miller, D. L., Puricelli, M. D., & Stack, M. S. (2012) · Biochemical Journal · doi:10.1042/bj20112017 · Cited by 76
SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis
Zhu, Y., Yan, Y., Principe, D. R., Zou, X., Vassilopoulos, A., & Gius, D. R. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-15 · Cited by 77
The critical role of cyclin D2 in cell cycle progression and tumorigenicity of glioblastoma stem cells
Koyama‐Nasu, R., Nasu‐Nishimura, Y., Todo, T., Ino, Y., Saito, N., Aburatani, H., Funato, K., Echizen, K., Sugano, H., Haruta, R., et al. (2012) · Oncogene · doi:10.1038/onc.2012.399 · Cited by 76
Cell cycle, proteolysis and cancer
Yamasaki, L., & Pagano, M. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.08.005 · Cited by 74
Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model
Belinsky, S. A., Grimes, M. J., Picchi, M. A., Mitchell, H. D., Stidley, C. A., Tesfaigzi, Y., Channell, M. M., Liu, Y., Casero, R. A., Baylin, S. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3184 · Cited by 74
The cyclin D1b splice variant: an old oncogene learns new tricks.
Knudsen, K. E. (2006) · Cell Division · doi:10.1186/1747-1028-1-15 · Cited by 76
Targeting Breast Cancer with CDK Inhibitors
Mayer, E. L. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0443-3 · Cited by 75
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib
Raspé, E., Coulonval, K., Pita, J. M. G., Paternot, S., Rothé, F., Twyffels, L., Brohée, S., Craciun, L., Larsimont, D., Kruys, V., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607084 · Cited by 76
Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
Rojas, J. J., Guedan, S., Searle, P. F., Martínez‐Quintanilla, J., Gil-Hoyos, R., Alcayaga‐Miranda, F., Cascalló, M., & Alemany, R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.173 · Cited by 74
Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer
Baird, S. K., Aerts, J. L., Eddaoudi, A., Lockley, M., Lemoine, N. R., & McNeish, I. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210977 · Cited by 75
Expression of the VRK (vaccinia‐related kinase) gene family of p53 regulators in murine hematopoietic development
Vega, F. M. D. L., Gonzalo, P., Gaspar, M.-L., & Lazo, P. A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00501-5 · Cited by 74
Reorganization of the host epigenome by a viral oncogenePreprint
Ferrari, R., Su, T., Li, B., Bonora, G., Oberai, A., Chan, Y. Y., Sasidharan, R., Berk, A. J., Pellegrini, M. A., & Kurdistani, S. K. (2012) · Genome Research · doi:10.1101/gr.132308.111 · Cited by 71
E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs
Zhang, E., Yin, D., Han, L., He, X., Si, X., Chen, W., Xia, R., Xu, T., Gu, D., De, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6745 · Cited by 73
Cellular senescence: a hitchhiker’s guide
Aravinthan, A. D. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 83
Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q
Tiemann, K., Heitling, U., Kosmahl, M., & Klöppel, G. (2007) · Modern Pathology · doi:10.1038/modpathol.3800902 · Cited by 73
ICOVIR-5 Shows E2F1 Addiction and Potent Antiglioma Effect In vivo
Alonso, M. M., Cascalló, M., Gomez‐Manzano, C., Jiang, H., Bekele, B. N., Pérez, A., Lang, F. F., Piao, Y., Alemany, R., & Fueyo-Margareto, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4675 · Cited by 73
Long non-coding RNA NEAT1 regulates E2F3 expression by competitively binding to miR-377 in non-small cell lung cancer
Zhang, J., Li, Y., Dong, M., & Wu, D. (2017) · Oncology Letters · doi:10.3892/ol.2017.6769 · Cited by 72
Deletion of Forkhead Box M1 Transcription Factor from Respiratory Epithelial Cells Inhibits Pulmonary Tumorigenesis
Wang, I., Meliton, L. N., Ren, X., Zhang, Y., Balli, D., Snyder, J. E., Whitsett, J. A., Kalinichenko, V. V., & Kalin, T. V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006609 · Cited by 72
The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage
Feldstein, O., Nizri, T., Doniger, T., Jacob, J., Rechavi, G., & Ginsberg, D. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-131 · Cited by 72
Immortalized keratinocyte lines derived from human embryonic stem cells
Iuchi, S., Dabelsteen, S., Easley, K. W., Rheinwald, J. G., & Green, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510953103 · Cited by 72
Markers of cellular senescence.
Carnero, A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_4 · Cited by 68
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
Uo, T., Sprenger, C. C. T., & Plymate, S. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.580617 · Cited by 76
Combined Large Cell Neuroendocrine and Endometrioid Carcinoma of the Endometrium
Mulvany, N. J., & Allen, D. G. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31806219c5 · Cited by 71
The Regulation of Cellular Functions by the p53 Protein: Cellular SenescencePreprint
Tonnessen-Murray, C. A., Lozano, G., & Jackson, J. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026112 · Cited by 76
Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives
Ausoni, S., Boscolo‐Rizzo, P., Singh, B., Mosto, M. C. D., Spinato, G., Tirelli, G., Spinato, R., & Azzarello, G. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9625-1 · Cited by 71
S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis
Martínez-Leal, J. F., Ferrer, I., Blanco‐Aparicio, C., Hernández‐Losa, J., y Cajal, S. R., Carnero, A., & LLeonart, M. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn198 · Cited by 71
C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions
Schertel, C., & Conradt, B. (2007) · Development · doi:10.1242/dev.004606 · Cited by 70
Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins
Zacharek, S. J., Xiong, Y., & Shumway, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2236 · Cited by 72
Collecting duct carcinoma of the kidney is associated withCDKN2Adeletion andSLCfamily gene up-regulation
Wang, J., Papanicolau‐Sengos, A., Chintala, S., Wei, L., Liu, B., Hu, Q., Miles, K. M., Conroy, J. M., Glenn, S. T., Costantini, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9093 · Cited by 69
Transcription regulation and human diseases
Villard, J. (2004) · Swiss Medical Weekly · doi:10.4414/smw.2004.10191 · Cited by 68
Rescue of key features of the p63‐null epithelial phenotype by inactivation of Ink4a and Arf
Su, X., Cho, M. S., Gi, Y. J., Ayanga, B. A., Sherr, C. J., & Flores, E. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.151 · Cited by 71
Self-citation
Posttranslational Modifications of the Retinoblastoma Tumor Suppressor Protein as Determinants of Function
MacDonald, J. I., & Dick, F. A. (2012) · Genes & Cancer · doi:10.1177/1947601912473305 · Cited by 71
Apoptosis signals in lymphoblasts induced by focused ultrasound
Abdollahi, A., Domhan, S., Jenne, J. W., Hallaj, M., Dell'Aqua, G., Mueckenthaler, M., Richter, A., Martin, H. R., Debus, J., Ansorge, W. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1601fje · Cited by 69
MYC levels govern hematopoietic tumor type and latency in transgenic mice
Smith, D. P., Bath, M. L., Metcalf, D., Harris, A. W., & Cory, S. (2006) · Blood · doi:10.1182/blood-2006-01-0172 · Cited by 67
Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs
Anderson, N. A., Cryan, J., Ahmed, A., Dai, H., McGonagle, G. A., Rozier, C., & Benowitz, A. B. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127106 · Cited by 69
Regulation of CDK4
Bockstaele, L., Coulonval, K., Kooken, H., Paternot, S., & Roger, P. P. (2006) · Cell Division · doi:10.1186/1747-1028-1-25 · Cited by 74
Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
Wierstra, I., & Alves, J. (2006) · Biological Chemistry · doi:10.1515/bc.2006.119 · Cited by 69
The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma
Frank, A. J., Hernán, R., Hollander, A. B., Lindsey, J. C., Lusher, M. E., Fuller, C. E., Clifford, S. C., & Gilbertson, R. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.016 · Cited by 68
Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias
Clappier, E., Cuccuini, W., Cayuela, J., Vecchione, D., Baruchel, A., Dombret, H., Sigaux, F., & Soulier, J. (2005) · Leukemia · doi:10.1038/sj.leu.2404008 · Cited by 68
CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point
Bisteau, X., Paternot, S., Bianca, C., Ecker, K., Coulonval, K., Groote, P. D., Declercq, W., Hengst, L., & Roger, P. P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003546 · Cited by 68
Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis
Shin, M.-K., Balsitis, S. J., Brake, T., & Lambert, P. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3711 · Cited by 67
EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
Gao, S.-B., Zheng, Q., Xu, B., Pan, C.-B., Li, K., Zhao, Y., Zheng, Q., Lin, X., Xue, L., & Jin, G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0034 · Cited by 67
Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK “Inhibitors”
Bockstaele, L., Kooken, H., Libert, F., Paternot, S., Dumont, J. E., de Launoit, Y., Roger, P. P., & Coulonval, K. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02006-05 · Cited by 67
Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo
Balsitis, S. J., Dick, F. A., Lee, D., Farrell, L., Hyde, R. K., Griep, A. E., Dyson, N. J., & Lambert, P. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11392-11402.2005 · Cited by 67
Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors
Martínez-Cruz, A. B., Santos, M., Lara, M. F., Segrelles, C., Ruiz, S., Moral, M., Lorz, C., García-Escudero, R., & Paramio, J. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3049 · Cited by 65
The ubiquitin–proteasome system and cancer
Devoy, A., Soane, T., Welchman, R., & Mayer, R. J. (2005) · Essays in Biochemistry · doi:10.1042/bse0410187 · Cited by 66
Transcriptome profiling of the C. elegans Rb ortholog reveals diverse developmental roles
Kirienko, N. V., & Fay, D. S. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.02.021 · Cited by 67
The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system
Macleod, K. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2504 · Cited by 68
Role of p53 and Rb in Ovarian Cancer
Corney, D. C., Flesken‐Nikitin, A., Choi, J., & Nikitin, A. Y. (2008) · Springer eBooks · doi:10.1007/978-0-387-68969-2_9 · Cited by 67
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 72
Stimulation of Steroid Receptor Coactivator-3 (SRC-3) Gene Overexpression by a Positive Regulatory Loop of E2F1 and SRC-3
Mussi, P., Yu, C., O’Malley, B. W., & Xu, J. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0522 · Cited by 65
In vivoBiological Activity of the Histone Deacetylase Inhibitor LAQ824 Is detectable with 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography
Leyton, J., Alao, J. P., Costa, M. D., Stavropoulou, A. V., Latigo, J. R., Perumal, M., Pillai, R. G., He, Q., Atadja, P. W., Lam, E. W. ‐., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3962 · Cited by 65
Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis
Chi, J., Li, J.-Z., Jia, J., Zhang, T., Liu, X.-M., & Yi, L. (2017) · Current Medical Science · doi:10.1007/s11596-017-1812-y · Cited by 64
American Cancer Society ( ACS )
Higgins, C. S., Martin, T. J., & Roginski, A. M. (2014) · Wiley eBooks · doi:10.1002/9781118660584.ese0105 · Cited by 65
Cellular senescence bypass screen identifies new putative tumor suppressor genes
Martínez-Leal, J. F., Fominaya, J. M., Cascón, A., Guijarro, M. V., Blanco‐Aparicio, C., LLeonart, M. E., Castro, M. E., y Cajal, S. R., Robledo, M., Beach, D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210846 · Cited by 64
New and unexpected: forkhead meets ARF
Costa, R. H., Kalinichenko, V. V., Major, M. L., & Raychaudhuri, P. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.007 · Cited by 65
Analysis and verification of the HMGB1 signaling pathway
Gong, H., Zuliani, P., Komuravelli, A., Faeder, J. R., & Clarke, E. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s7-s10 · Cited by 64
E2F and p53 Induce Apoptosis Independently during Drosophila Development but Intersect in the Context of DNA Damage
Moon, N.-S., Stefano, L. D., Morris, E. J., Patel, R. G., White, K., & Dyson, N. J. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000153 · Cited by 64
PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses
Knelson, E. H., Patel, S. A., & Sands, J. M. (2021) · Cancers · doi:10.3390/cancers13040727 · Cited by 65
Viruses – seeking and destroying the tumor program
O’Shea, C. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209047 · Cited by 65
Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein
Sheldon, L. A. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1338221 · Cited by 63

Authors: Sherr, C. J., & McCormick, F.
Affiliations: St. Jude Children's Research Hospital (US)
University of California, San Francisco (US)
Corresponding author: Sherr, Charles J
ORCID: Sherr, Charles J
McCormick, Frank
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2002-08
Volume: 2
Issue: 2
Pages: 103-112
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/s1535-6108(02)00102-2
OpenAlex: W1992708996
Cited by: 1,690
References: 122
Citations by year: 2026: 31 · 2025: 40 · 2024: 36 · 2023: 60 · 2022: 56 · 2021: 62 · 2020: 62 · 2019: 67 · 2018: 75 · 2017: 67 · 2016: 60 · 2015: 71 · 2014: 88 · 2013: 81 · 2012: 90
FWCI: 7.67
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4003 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: retinoblastoma protein, p53, tumor suppressor, malignant transformation, signaling pathways, cancer etiology, tumor-specific therapy, oncogenic transformation
MeSH terms: Cell Cycle, DNA-Binding Proteins, Humans, Neoplasms, Transcription Factors, Signal Transduction, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, E2F Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The RB and p53 pathways in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks